Sotheara Cheav - 04 Jun 2026 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
05 Jun 2026, 21:00:24 UTC
Prior SEC filing
19 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mark McKechnie, Attorney-in-Fact for Sotheara Cheav

Key filing fact

Sotheara Cheav filed Form 4 for ACM Research, Inc. (ACMR) on 05 Jun 2026.

Key facts

  • This page summarizes Sotheara Cheav's Form 4 filing for ACM Research, Inc. (ACMR).
  • 11 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 05 Jun 2026, 21:00.

Change

  • Previous filing in this sequence was filed on 19 Sep 2025.
  • Current net transaction value: -$1,585,923.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001721279 Primary reporting owner

Cheav Sotheara

Relationship
Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the Issuer.
Address
C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT
Signature
/s/ Mark McKechnie, Attorney-in-Fact for Sotheara Cheav
Signature date
05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACMR transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+13,351
Change %
+13%
Price
$13.89*
Shares after
113,353
Date
04 Jun 2026
Ownership
Direct
ACMR transaction

Class A Common Stock

Sale

Transaction value
$109,304
Shares
-1,300
Change %
-1.1%
Price
$84.08
Shares after
112,053
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1, F2
ACMR transaction

Class A Common Stock

Sale

Transaction value
$784,033
Shares
-9,212
Change %
-8.2%
Price
$85.11
Shares after
102,841
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1, F3
ACMR transaction

Class A Common Stock

Sale

Transaction value
$243,501
Shares
-2,839
Change %
-2.8%
Price
$85.77
Shares after
100,002
Date
04 Jun 2026
Ownership
Direct
Footnotes
F1, F4
ACMR transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+5,399
Change %
+5.4%
Price
$13.89*
Shares after
105,401
Date
05 Jun 2026
Ownership
Direct
ACMR transaction

Class A Common Stock

Sale

Transaction value
$194,844
Shares
-2,384
Change %
-2.3%
Price
$81.73
Shares after
103,017
Date
05 Jun 2026
Ownership
Direct
Footnotes
F1, F5
ACMR transaction

Class A Common Stock

Sale

Transaction value
$79,966
Shares
-968
Change %
-0.94%
Price
$82.61
Shares after
102,049
Date
05 Jun 2026
Ownership
Direct
Footnotes
F1, F6
ACMR transaction

Class A Common Stock

Sale

Transaction value
$33,604
Shares
-400
Change %
-0.39%
Price
$84.01
Shares after
101,649
Date
05 Jun 2026
Ownership
Direct
Footnotes
F1, F7
ACMR transaction

Class A Common Stock

Sale

Transaction value
$140,670
Shares
-1,647
Change %
-1.6%
Price
$85.41
Shares after
100,002
Date
05 Jun 2026
Ownership
Direct
Footnotes
F1, F8

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACMR transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-13,351
Change %
-24%
Price
$0.000000*
Shares after
42,899
Date
04 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
13,351
Exercise price
$13.89
Footnotes
F9
ACMR transaction Derivative

Stock Option

Options Exercise

Transaction value
Shares
-5,399
Change %
-13%
Price
$0.000000*
Shares after
37,500
Date
05 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
5,399
Exercise price
$13.89
Footnotes
F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 9 footnotes

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.61 to $84.4, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7), and (8) to this Form 4.

Footnote F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.63 to $85.6, inclusive.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.7 to $86.19, inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.22 to $82.07, inclusive.

Footnote F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.38 to $82.89, inclusive.

Footnote F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.85 to $84.5, inclusive.

Footnote F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.27 to $85.72, inclusive.

Footnote F9

The option is fully vested and exercisable.

SEC remarks

Senior Vice President, Manufacturing of ACM Research (Shanghai), Inc., a subsidiary of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .